Predicting real-world overall survival for post-operative pancreatic ductal adenocarcinoma: An ASCO CancerLinQ Discovery analysis

被引：0
|
作者：
Ahmed, Kaleem Sohail
Issaka, Sheriff M.
Marcinak, Clayton Thomas
Zafar, Syed Nabeel
机构：
[1] Univ Wisconsin, Dept Surg, Madison, WI USA
[2] Univ Wisconsin, Dept Surg, Div Surg Oncol, Madison, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4169
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Using oncology real-world evidence for quality improvement and discovery: the case for ASCO's CancerLinQ
    Miller, Robert S.
    Wong, Jennifer L.
    FUTURE ONCOLOGY, 2018, 14 (01) : 5 - 8
  • [2] Real-world overall survival of patients diagnosed with recurrent versus de novo metastatic pancreatic ductal adenocarcinoma (PDAC).
    O'Reilly, Eileen Mary
    Yu, Kenneth H.
    Lamarre, Neil
    Surinach, Andy
    Cockrum, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Pitfalls with analyses of real-world data: A look at ASCO's CancerLinQ Discovery Multiple Myeloma dataset
    Shou, Karen J.
    Thornton, Jennifer A.
    Sunderland, Kevin
    DeStefano, Christin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Real-world Big-data: Strengths and weaknesses of ASCO's CancerLinQ® discovery multiple myeloma dataset
    DeStefano, Christin B.
    Thornton, Jennifer A.
    Gibson, Steven J.
    Pham, Kevin
    Miller, Robert S.
    Sunderland, Kevin
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (06) : 835 - 837
  • [5] Real-world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma
    Yu, Kenneth H.
    Ozer, Muhammet
    Cockrum, Paul
    Surinach, Andy
    Wang, Shu
    Chu, Bong Chul
    CANCER MEDICINE, 2021, 10 (24): : 8934 - 8943
  • [6] NALIRIFOX Versus FOLFOX as First-oLine Treatment of Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC): Real-World Comparative Overall (OS) Survival Analysis
    O'Reilly, Eileen
    Li, Jia
    DerSarkissian, Maral
    Chang, Rose
    Cheng, Mu
    Yu, Louise
    Rane, Deepali
    Zhang, Li
    Xiao, Zhimin
    Benzaghou, Fawzi
    Duh, Mei Sheng
    Chen, Huanyu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 176 - 176
  • [7] Higher body mass index indicated better overall survival in pancreatic ductal adenocarcinoma patients: a real-world study of 2010 patients
    Ningzhen Fu
    Yu Jiang
    Kai Qin
    Hao Chen
    Xiaxing Deng
    Baiyong Shen
    BMC Cancer, 21
  • [8] Higher body mass index indicated better overall survival in pancreatic ductal adenocarcinoma patients: a real-world study of 2010 patients
    Fu, Ningzhen
    Jiang, Yu
    Qin, Kai
    Chen, Hao
    Deng, Xiaxing
    Shen, Baiyong
    BMC CANCER, 2021, 21 (01)
  • [9] A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma
    Xu, Jie
    Shi, Ke-Qing
    Chen, Bi-Cheng
    Huang, Zhi-Peng
    Lu, Fei-Yu
    Zhou, Meng-Tao
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (07) : 1394 - 1402
  • [10] Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis
    Elmi, Azadeh
    Murphy, Janet
    Hedgire, Sandeep
    McDermott, Shaunagh
    Abtahi, Seyed-Mahdi
    Halpern, Elkan
    Fernandez-del Castillo, Carlos
    Harisinghani, Mukesh
    ABDOMINAL RADIOLOGY, 2017, 42 (08) : 2101 - 2107
12345